0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracellular Matrix Scaffold Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-25E17894
Home | Market Reports | Science| Biological Sciences
Global Extracellular Matrix Scaffold Market Research Report 2024
BUY CHAPTERS

Global Extracellular Matrix Scaffold Market Research Report 2024

Code: QYRE-Auto-25E17894
Report
August 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Extracellular Matrix Scaffold Market Size

The global Extracellular Matrix Scaffold market was valued at US$ 36.8 million in 2023 and is anticipated to reach US$ 61.8 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.

Extracellular Matrix Scaffold Market

Extracellular Matrix Scaffold Market

An extracellular matrix (ECM) scaffold is a three-dimensional structure composed of proteins, glycoproteins, and polysaccharides that mimic the natural ECM found in tissues. These scaffolds provide a supportive framework for cells to attach, grow, and differentiate, facilitating tissue regeneration and repair. They are often used in tissue engineering and regenerative medicine to create environments conducive to cell proliferation and function, aiming to restore damaged tissues or organs. ECM scaffolds can be derived from natural sources, such as decellularized tissues, or synthesized using biomaterials designed to replicate the properties of natural ECM. These scaffolds promote cellular activities by providing biochemical and mechanical cues that influence cell behavior, thus playing a crucial role in the development of functional tissue constructs​.
North American market for Extracellular Matrix Scaffold is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracellular Matrix Scaffold is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracellular Matrix Scaffold in Biopharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracellular Matrix Scaffold include Merck, Smith&Nephew, DSM Biomedical, Corning, Thermo Fisher, AMSBIO, Mimetas, FUJIFILM, CellSystems, Advanced BioMatrix, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracellular Matrix Scaffold, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Matrix Scaffold.
The Extracellular Matrix Scaffold market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracellular Matrix Scaffold market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracellular Matrix Scaffold companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Extracellular Matrix Scaffold Market Report

Report Metric Details
Report Name Extracellular Matrix Scaffold Market
Accounted market size in 2023 US$ 36.8 million
Forecasted market size in 2030 US$ 61.8 million
CAGR 7.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Animal-derived EMC
  • Human-derived EMC
  • Synthetic EMC
Segment by Application
  • Biopharmaceuticals
  • Clinical Medicine
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Smith&Nephew, DSM Biomedical, Corning, Thermo Fisher, AMSBIO, Mimetas, FUJIFILM, CellSystems, Advanced BioMatrix, Bio-Techne, AROA Biosurgery, Integra LifeSciences, Elutia, ReproCELL, Biolamina, Tissue Regenix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Extracellular Matrix Scaffold company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Extracellular Matrix Scaffold Market growing?

Ans: The Extracellular Matrix Scaffold Market witnessing a CAGR of 7.7% during the forecast period 2024-2030.

What is the Extracellular Matrix Scaffold Market size in 2030?

Ans: The Extracellular Matrix Scaffold Market size in 2030 will be US$ 61.8 million.

Who are the main players in the Extracellular Matrix Scaffold Market report?

Ans: The main players in the Extracellular Matrix Scaffold Market are Merck, Smith&Nephew, DSM Biomedical, Corning, Thermo Fisher, AMSBIO, Mimetas, FUJIFILM, CellSystems, Advanced BioMatrix, Bio-Techne, AROA Biosurgery, Integra LifeSciences, Elutia, ReproCELL, Biolamina, Tissue Regenix

What are the Application segmentation covered in the Extracellular Matrix Scaffold Market report?

Ans: The Applications covered in the Extracellular Matrix Scaffold Market report are Biopharmaceuticals, Clinical Medicine, Academic Research, Others

What are the Type segmentation covered in the Extracellular Matrix Scaffold Market report?

Ans: The Types covered in the Extracellular Matrix Scaffold Market report are Animal-derived EMC, Human-derived EMC, Synthetic EMC

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Matrix Scaffold Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Animal-derived EMC
1.2.3 Human-derived EMC
1.2.4 Synthetic EMC
1.3 Market by Application
1.3.1 Global Extracellular Matrix Scaffold Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceuticals
1.3.3 Clinical Medicine
1.3.4 Academic Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Matrix Scaffold Market Perspective (2019-2030)
2.2 Global Extracellular Matrix Scaffold Growth Trends by Region
2.2.1 Global Extracellular Matrix Scaffold Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extracellular Matrix Scaffold Historic Market Size by Region (2019-2024)
2.2.3 Extracellular Matrix Scaffold Forecasted Market Size by Region (2025-2030)
2.3 Extracellular Matrix Scaffold Market Dynamics
2.3.1 Extracellular Matrix Scaffold Industry Trends
2.3.2 Extracellular Matrix Scaffold Market Drivers
2.3.3 Extracellular Matrix Scaffold Market Challenges
2.3.4 Extracellular Matrix Scaffold Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Matrix Scaffold Players by Revenue
3.1.1 Global Top Extracellular Matrix Scaffold Players by Revenue (2019-2024)
3.1.2 Global Extracellular Matrix Scaffold Revenue Market Share by Players (2019-2024)
3.2 Global Extracellular Matrix Scaffold Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Extracellular Matrix Scaffold Revenue
3.4 Global Extracellular Matrix Scaffold Market Concentration Ratio
3.4.1 Global Extracellular Matrix Scaffold Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Matrix Scaffold Revenue in 2023
3.5 Global Key Players of Extracellular Matrix Scaffold Head office and Area Served
3.6 Global Key Players of Extracellular Matrix Scaffold, Product and Application
3.7 Global Key Players of Extracellular Matrix Scaffold, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracellular Matrix Scaffold Breakdown Data by Type
4.1 Global Extracellular Matrix Scaffold Historic Market Size by Type (2019-2024)
4.2 Global Extracellular Matrix Scaffold Forecasted Market Size by Type (2025-2030)
5 Extracellular Matrix Scaffold Breakdown Data by Application
5.1 Global Extracellular Matrix Scaffold Historic Market Size by Application (2019-2024)
5.2 Global Extracellular Matrix Scaffold Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Extracellular Matrix Scaffold Market Size (2019-2030)
6.2 North America Extracellular Matrix Scaffold Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Extracellular Matrix Scaffold Market Size by Country (2019-2024)
6.4 North America Extracellular Matrix Scaffold Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Matrix Scaffold Market Size (2019-2030)
7.2 Europe Extracellular Matrix Scaffold Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Extracellular Matrix Scaffold Market Size by Country (2019-2024)
7.4 Europe Extracellular Matrix Scaffold Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Matrix Scaffold Market Size (2019-2030)
8.2 Asia-Pacific Extracellular Matrix Scaffold Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Extracellular Matrix Scaffold Market Size by Region (2019-2024)
8.4 Asia-Pacific Extracellular Matrix Scaffold Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extracellular Matrix Scaffold Market Size (2019-2030)
9.2 Latin America Extracellular Matrix Scaffold Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Extracellular Matrix Scaffold Market Size by Country (2019-2024)
9.4 Latin America Extracellular Matrix Scaffold Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Matrix Scaffold Market Size (2019-2030)
10.2 Middle East & Africa Extracellular Matrix Scaffold Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Extracellular Matrix Scaffold Market Size by Country (2019-2024)
10.4 Middle East & Africa Extracellular Matrix Scaffold Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Extracellular Matrix Scaffold Introduction
11.1.4 Merck Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Smith&Nephew
11.2.1 Smith&Nephew Company Details
11.2.2 Smith&Nephew Business Overview
11.2.3 Smith&Nephew Extracellular Matrix Scaffold Introduction
11.2.4 Smith&Nephew Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.2.5 Smith&Nephew Recent Development
11.3 DSM Biomedical
11.3.1 DSM Biomedical Company Details
11.3.2 DSM Biomedical Business Overview
11.3.3 DSM Biomedical Extracellular Matrix Scaffold Introduction
11.3.4 DSM Biomedical Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.3.5 DSM Biomedical Recent Development
11.4 Corning
11.4.1 Corning Company Details
11.4.2 Corning Business Overview
11.4.3 Corning Extracellular Matrix Scaffold Introduction
11.4.4 Corning Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.4.5 Corning Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Details
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Extracellular Matrix Scaffold Introduction
11.5.4 Thermo Fisher Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.5.5 Thermo Fisher Recent Development
11.6 AMSBIO
11.6.1 AMSBIO Company Details
11.6.2 AMSBIO Business Overview
11.6.3 AMSBIO Extracellular Matrix Scaffold Introduction
11.6.4 AMSBIO Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.6.5 AMSBIO Recent Development
11.7 Mimetas
11.7.1 Mimetas Company Details
11.7.2 Mimetas Business Overview
11.7.3 Mimetas Extracellular Matrix Scaffold Introduction
11.7.4 Mimetas Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.7.5 Mimetas Recent Development
11.8 FUJIFILM
11.8.1 FUJIFILM Company Details
11.8.2 FUJIFILM Business Overview
11.8.3 FUJIFILM Extracellular Matrix Scaffold Introduction
11.8.4 FUJIFILM Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.8.5 FUJIFILM Recent Development
11.9 CellSystems
11.9.1 CellSystems Company Details
11.9.2 CellSystems Business Overview
11.9.3 CellSystems Extracellular Matrix Scaffold Introduction
11.9.4 CellSystems Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.9.5 CellSystems Recent Development
11.10 Advanced BioMatrix
11.10.1 Advanced BioMatrix Company Details
11.10.2 Advanced BioMatrix Business Overview
11.10.3 Advanced BioMatrix Extracellular Matrix Scaffold Introduction
11.10.4 Advanced BioMatrix Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.10.5 Advanced BioMatrix Recent Development
11.11 Bio-Techne
11.11.1 Bio-Techne Company Details
11.11.2 Bio-Techne Business Overview
11.11.3 Bio-Techne Extracellular Matrix Scaffold Introduction
11.11.4 Bio-Techne Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.11.5 Bio-Techne Recent Development
11.12 AROA Biosurgery
11.12.1 AROA Biosurgery Company Details
11.12.2 AROA Biosurgery Business Overview
11.12.3 AROA Biosurgery Extracellular Matrix Scaffold Introduction
11.12.4 AROA Biosurgery Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.12.5 AROA Biosurgery Recent Development
11.13 Integra LifeSciences
11.13.1 Integra LifeSciences Company Details
11.13.2 Integra LifeSciences Business Overview
11.13.3 Integra LifeSciences Extracellular Matrix Scaffold Introduction
11.13.4 Integra LifeSciences Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.13.5 Integra LifeSciences Recent Development
11.14 Elutia
11.14.1 Elutia Company Details
11.14.2 Elutia Business Overview
11.14.3 Elutia Extracellular Matrix Scaffold Introduction
11.14.4 Elutia Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.14.5 Elutia Recent Development
11.15 ReproCELL
11.15.1 ReproCELL Company Details
11.15.2 ReproCELL Business Overview
11.15.3 ReproCELL Extracellular Matrix Scaffold Introduction
11.15.4 ReproCELL Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.15.5 ReproCELL Recent Development
11.16 Biolamina
11.16.1 Biolamina Company Details
11.16.2 Biolamina Business Overview
11.16.3 Biolamina Extracellular Matrix Scaffold Introduction
11.16.4 Biolamina Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.16.5 Biolamina Recent Development
11.17 Tissue Regenix
11.17.1 Tissue Regenix Company Details
11.17.2 Tissue Regenix Business Overview
11.17.3 Tissue Regenix Extracellular Matrix Scaffold Introduction
11.17.4 Tissue Regenix Revenue in Extracellular Matrix Scaffold Business (2019-2024)
11.17.5 Tissue Regenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Extracellular Matrix Scaffold Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Animal-derived EMC
 Table 3. Key Players of Human-derived EMC
 Table 4. Key Players of Synthetic EMC
 Table 5. Global Extracellular Matrix Scaffold Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Extracellular Matrix Scaffold Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Extracellular Matrix Scaffold Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Extracellular Matrix Scaffold Market Share by Region (2019-2024)
 Table 9. Global Extracellular Matrix Scaffold Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Extracellular Matrix Scaffold Market Share by Region (2025-2030)
 Table 11. Extracellular Matrix Scaffold Market Trends
 Table 12. Extracellular Matrix Scaffold Market Drivers
 Table 13. Extracellular Matrix Scaffold Market Challenges
 Table 14. Extracellular Matrix Scaffold Market Restraints
 Table 15. Global Extracellular Matrix Scaffold Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Extracellular Matrix Scaffold Market Share by Players (2019-2024)
 Table 17. Global Top Extracellular Matrix Scaffold Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Matrix Scaffold as of 2023)
 Table 18. Ranking of Global Top Extracellular Matrix Scaffold Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Extracellular Matrix Scaffold Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Extracellular Matrix Scaffold, Headquarters and Area Served
 Table 21. Global Key Players of Extracellular Matrix Scaffold, Product and Application
 Table 22. Global Key Players of Extracellular Matrix Scaffold, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Extracellular Matrix Scaffold Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Extracellular Matrix Scaffold Revenue Market Share by Type (2019-2024)
 Table 26. Global Extracellular Matrix Scaffold Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Extracellular Matrix Scaffold Revenue Market Share by Type (2025-2030)
 Table 28. Global Extracellular Matrix Scaffold Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Extracellular Matrix Scaffold Revenue Market Share by Application (2019-2024)
 Table 30. Global Extracellular Matrix Scaffold Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Extracellular Matrix Scaffold Revenue Market Share by Application (2025-2030)
 Table 32. North America Extracellular Matrix Scaffold Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Extracellular Matrix Scaffold Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Extracellular Matrix Scaffold Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Extracellular Matrix Scaffold Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Extracellular Matrix Scaffold Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Extracellular Matrix Scaffold Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Extracellular Matrix Scaffold Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Extracellular Matrix Scaffold Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Extracellular Matrix Scaffold Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Extracellular Matrix Scaffold Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Extracellular Matrix Scaffold Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Extracellular Matrix Scaffold Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Extracellular Matrix Scaffold Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Extracellular Matrix Scaffold Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Extracellular Matrix Scaffold Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Merck Company Details
 Table 48. Merck Business Overview
 Table 49. Merck Extracellular Matrix Scaffold Product
 Table 50. Merck Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 51. Merck Recent Development
 Table 52. Smith&Nephew Company Details
 Table 53. Smith&Nephew Business Overview
 Table 54. Smith&Nephew Extracellular Matrix Scaffold Product
 Table 55. Smith&Nephew Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 56. Smith&Nephew Recent Development
 Table 57. DSM Biomedical Company Details
 Table 58. DSM Biomedical Business Overview
 Table 59. DSM Biomedical Extracellular Matrix Scaffold Product
 Table 60. DSM Biomedical Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 61. DSM Biomedical Recent Development
 Table 62. Corning Company Details
 Table 63. Corning Business Overview
 Table 64. Corning Extracellular Matrix Scaffold Product
 Table 65. Corning Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 66. Corning Recent Development
 Table 67. Thermo Fisher Company Details
 Table 68. Thermo Fisher Business Overview
 Table 69. Thermo Fisher Extracellular Matrix Scaffold Product
 Table 70. Thermo Fisher Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 71. Thermo Fisher Recent Development
 Table 72. AMSBIO Company Details
 Table 73. AMSBIO Business Overview
 Table 74. AMSBIO Extracellular Matrix Scaffold Product
 Table 75. AMSBIO Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 76. AMSBIO Recent Development
 Table 77. Mimetas Company Details
 Table 78. Mimetas Business Overview
 Table 79. Mimetas Extracellular Matrix Scaffold Product
 Table 80. Mimetas Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 81. Mimetas Recent Development
 Table 82. FUJIFILM Company Details
 Table 83. FUJIFILM Business Overview
 Table 84. FUJIFILM Extracellular Matrix Scaffold Product
 Table 85. FUJIFILM Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 86. FUJIFILM Recent Development
 Table 87. CellSystems Company Details
 Table 88. CellSystems Business Overview
 Table 89. CellSystems Extracellular Matrix Scaffold Product
 Table 90. CellSystems Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 91. CellSystems Recent Development
 Table 92. Advanced BioMatrix Company Details
 Table 93. Advanced BioMatrix Business Overview
 Table 94. Advanced BioMatrix Extracellular Matrix Scaffold Product
 Table 95. Advanced BioMatrix Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 96. Advanced BioMatrix Recent Development
 Table 97. Bio-Techne Company Details
 Table 98. Bio-Techne Business Overview
 Table 99. Bio-Techne Extracellular Matrix Scaffold Product
 Table 100. Bio-Techne Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 101. Bio-Techne Recent Development
 Table 102. AROA Biosurgery Company Details
 Table 103. AROA Biosurgery Business Overview
 Table 104. AROA Biosurgery Extracellular Matrix Scaffold Product
 Table 105. AROA Biosurgery Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 106. AROA Biosurgery Recent Development
 Table 107. Integra LifeSciences Company Details
 Table 108. Integra LifeSciences Business Overview
 Table 109. Integra LifeSciences Extracellular Matrix Scaffold Product
 Table 110. Integra LifeSciences Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 111. Integra LifeSciences Recent Development
 Table 112. Elutia Company Details
 Table 113. Elutia Business Overview
 Table 114. Elutia Extracellular Matrix Scaffold Product
 Table 115. Elutia Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 116. Elutia Recent Development
 Table 117. ReproCELL Company Details
 Table 118. ReproCELL Business Overview
 Table 119. ReproCELL Extracellular Matrix Scaffold Product
 Table 120. ReproCELL Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 121. ReproCELL Recent Development
 Table 122. Biolamina Company Details
 Table 123. Biolamina Business Overview
 Table 124. Biolamina Extracellular Matrix Scaffold Product
 Table 125. Biolamina Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 126. Biolamina Recent Development
 Table 127. Tissue Regenix Company Details
 Table 128. Tissue Regenix Business Overview
 Table 129. Tissue Regenix Extracellular Matrix Scaffold Product
 Table 130. Tissue Regenix Revenue in Extracellular Matrix Scaffold Business (2019-2024) & (US$ Million)
 Table 131. Tissue Regenix Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Extracellular Matrix Scaffold Picture
 Figure 2. Global Extracellular Matrix Scaffold Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Extracellular Matrix Scaffold Market Share by Type: 2023 VS 2030
 Figure 4. Animal-derived EMC Features
 Figure 5. Human-derived EMC Features
 Figure 6. Synthetic EMC Features
 Figure 7. Global Extracellular Matrix Scaffold Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Extracellular Matrix Scaffold Market Share by Application: 2023 VS 2030
 Figure 9. Biopharmaceuticals Case Studies
 Figure 10. Clinical Medicine Case Studies
 Figure 11. Academic Research Case Studies
 Figure 12. Others Case Studies
 Figure 13. Extracellular Matrix Scaffold Report Years Considered
 Figure 14. Global Extracellular Matrix Scaffold Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Extracellular Matrix Scaffold Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Extracellular Matrix Scaffold Market Share by Region: 2023 VS 2030
 Figure 17. Global Extracellular Matrix Scaffold Market Share by Players in 2023
 Figure 18. Global Top Extracellular Matrix Scaffold Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Matrix Scaffold as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Extracellular Matrix Scaffold Revenue in 2023
 Figure 20. North America Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Extracellular Matrix Scaffold Market Share by Country (2019-2030)
 Figure 22. United States Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Extracellular Matrix Scaffold Market Share by Country (2019-2030)
 Figure 26. Germany Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Extracellular Matrix Scaffold Market Share by Region (2019-2030)
 Figure 34. China Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Extracellular Matrix Scaffold Market Share by Country (2019-2030)
 Figure 42. Mexico Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Extracellular Matrix Scaffold Market Share by Country (2019-2030)
 Figure 46. Turkey Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Extracellular Matrix Scaffold Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Merck Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 50. Smith&Nephew Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 51. DSM Biomedical Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 52. Corning Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 53. Thermo Fisher Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 54. AMSBIO Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 55. Mimetas Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 56. FUJIFILM Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 57. CellSystems Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 58. Advanced BioMatrix Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 59. Bio-Techne Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 60. AROA Biosurgery Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 61. Integra LifeSciences Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 62. Elutia Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 63. ReproCELL Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 64. Biolamina Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 65. Tissue Regenix Revenue Growth Rate in Extracellular Matrix Scaffold Business (2019-2024)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

DNA And RNA Synthesis Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-8T14376
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Add to Cart

Global Single Cell RNA Sequencing Service Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22U18216
Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Competent Yeast Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-3I14424
Thu Oct 17 00:00:00 UTC 2024

Add to Cart